DNA Stock Analysis: Buy, Sell, or Hold?
DNA - Ginkgo Bioworks Holdings, Inc.
$6.90
0.11 (1.62%)
▲
5d:
+7.64%
30d:
+3.14%
90d:
-16.97%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Distribution
DNA is up 5.9% this week, but smart money is buying puts. Top strike: $5 2026-06-18 with 603 OI. Put ratio: 68% View Scanner →
Strength: 4.7/10
Get Alerted When DNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: DNA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: DNA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: DNA is currently trading at $6.90, which is considered fair relative to its 30-day fair value range of $6.05 to $7.97.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $5.37, while resistance sits at $7.65.
Market Sentiment: DNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.67 (+25.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $5.37, while resistance sits at $7.65.
Market Sentiment: DNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.67 (+25.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$6.05 -
$7.97
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.6% below Wall St target ($8.67)
Fair Price Analysis
30-Day Fair Range
$6.05 -
$7.97
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$5.37
Resistance Level
$7.65
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.79
Wall Street Target
$8.67
(+25.6%)
Revenue Growth (YoY)
-23.8%
Profit Margin
-183.8%
Share & Embed Analysis
Last updated: April 02, 2026 11:08 PM ET
Data refreshes hourly during market hours. Next update: 12:08 AM
Data refreshes hourly during market hours. Next update: 12:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Steven P Coen
SELL
708 shares
2026-03-16
Steven P Coen
SELL
972 shares
2026-01-20
Steven P Coen
SELL
736 shares
2025-12-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 62 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |
Advanced DNA Option Strategies
Professional options setups generated by AI based on today's DNA price and gamma walls.
